John McCamant joined the Medical Technology Stock Letter as Associate Editor in 1987 and was named Editor of this leading investment newsletter in August 2000. Mr. McCamant has spent twenty five years on the frontlines of biotechnology investing. As an equities analyst for the American Healthcare Fund, he uncovered investment opportunities and guided investment strategy. At Burrill & Company, a San Francisco-based private merchant bank, he was a lead in raising $75 million for a venture capital fund. Mr. McCamant has established an extensive network that includes contacts throughout the investment banking and venture capital communities. His expertise in biotechnology investments is a subject of media interest. He is frequently consulted and quoted by The Washington Post, Business Week, Reuter’s, Bloomberg, CBS Marketwatch. John lives in San Francisco with his wife and daughter.
---------------------------------
John talks to Curt Renz with Curt Renz Capital Resources discussing the current economy. Recorded July 27, 2011
-------------------------------
On October 16, 2009 John talked to The Burrill Report's Daniel Levine about Acquisitions and IPOs. Click to Listen.
Below, John talks to Bloomberg's Rhonda Schaffler.
Recorded November 13, 2008